CARY, North Carolina – Verdesian Life Sciences, a leader in developing patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies, announced today that it has acquired Cytozyme Laboratories, Inc. The addition of Cytozyme provides additional value to Verdesian and strengthens its position as The Nutrient Use Efficiency People.

Based in Salt Lake City, Utah, Cytozyme boasts decades of innovation aimed at progressive growers.
“For more than four decades, Cytozyme’s mission has been to help farmers achieve sustainable yields through innovative solutions,” said Cytozyme CEO Eric Baughman. “We firmly believe that Verdesian Life Sciences has the technology, capabilities, and the people to continue that mission in a way that is true to our ideals. Our two companies’ product mixes are incredibly complementary; this is a great day for growers everywhere.”
Since its start in 2012, Verdesian has grown into a market leader in nutrient use efficiency technologies such as AVAIL®, NutriSphere-N®, N-Charge G, Take Off® LS, MicroSync® products, Primacy ALPHA®, Nutri-Phite®, Primo R1, and more.
“This acquisition is part of Verdesian’s broader merger and acquisition growth strategy toward maintaining leadership across the nutrient use efficiency space,” said Rick Riegner, EVP of Strategy & Business Development, Verdesian, “and it is further evidence of the continued embrace of products that offer sustainable solutions to farmers.”